Matthew Buten

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New Haven, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ George Clark, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Matthew Buten

Form 4 holding Chief Financial Officer

Biohaven Ltd.

Security class
Common Shares
Shares / value
195,652
Estimated value
$1,942,824
Report date
05 Jan 2026
Price
$9.93
Ownership
Direct
Form 4 holding Chief Financial Officer

Biohaven Ltd.

Security class
Stock Options (Right to buy)
Shares / value
175,000
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Financial Officer

Biohaven Ltd.

Security class
Restricted Share Unit Award
Shares / value
8,500
Estimated value
Report date
05 Jan 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Financial Officer

Biohaven Pharmaceutical Holding Co Ltd.

Security class
Restricted Share Unit Award
Shares / value
0
Estimated value
Report date
03 Oct 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Financial Officer

Biohaven Pharmaceutical Holding Co Ltd.

Security class
Stock Options (Right to Buy)
Shares / value
0
Estimated value
Report date
03 Oct 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Matthew Buten

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .